Article
FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Sept 2014
Beyda Nicholas D, John Julie, Kilic Abdullah, Alam Mohammad J, Lasco Todd M, Garey Kevin W
Abstract excerpt
BACKGROUND: Echinocandins are recommended for Candia glabrata candidemia. Mutations in the FKS1 and FKS2 genes are associated with echinocandin resistance. Few studies have assessed risk factors for FKS mutant isolates and outcomes in patients receiving micafungin treatment. METHODS: Patients with C. glabrata bloodstream infection admitted to a large, tertiary care hospital between 2009 and 2012 were included in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
